(For a live blog on European stocks, type LIVE/ in an Eikon
news window)
Sept 7 (Reuters) - European shares rebounded on Monday after
a Wall Street-led rout in technology stocks kept global
sentiment subdued in the previous week, with investors keeping a
close watch on COVID-19 vaccine developments.
Australia expects to receive its first batches of a
potential COVID-19 vaccine in January after a deal was struck
with CSL CSL.AX to manufacture two vaccines - one developed by
rival AstraZeneca AZN.L and Oxford University, and another in
CSL's own labs with the University of Queensland. AstraZeneca rose 1.5%. The European healthcare sector index
.SXDP jumped 0.9%.
The STOXX 600 index .STOXX was 0.8% higher by 0709 GMT,
with Frankfurt shares .GDAXI leading gains after rising 1%.
Shares of insurers .SXIP , banks .SX7P and automakers
.SXAP climbed more than 1% in early trading.